Active

PHARMARIVE

Switched

BE0521688764

Rechtspersoon Private limited company 1 establishment

Gérardstraat 150, 1040 Etterbeek Detailhandel in farmaceutische producten

Active for

13 year, 6 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ 166,358

▲ 11% vs 2024

Profit

Caution

€ -19,028

▼ 65% vs 2024

Debts

High

€ 1.7 million

▲ 1% vs 2024

PHARMARIVE from Etterbeek, company number BE0521688764, closed financial year 2025 with a result of € -19,028 after tax. For that financial year PHARMARIVE recorded a gross margin of € 166,358 and equity of € 114,888. Compared with financial year 2024, the result moved from € -11,512 to € -19,028. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 22, 2026.

What happened at PHARMARIVE?

What happened at PHARMARIVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 19,028. filed late Source: NBB ↗
  • BLUESTONE SRL became a director. NBB
  • New establishment in Kraainem. KBO
  • Start of the company according to the CBE. KBO

In short

From € 12,956 loss in 2021 to € 19,028 loss in 2025.

Paid € 2 in corporate taxes since 2021.

Best year ever: 2022, with € 26,028 profit.

On average € 87,600 of value added per employee in 2025.

A new publication or filing at PHARMARIVE? We notify you, reason included.

Follow PHARMARIVE

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind PHARMARIVE is BLUESTONE SRL. BLUESTONE SRL is also behind COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS and IMMOLENANS.

See the full network in the app

Directors

According to the 2025 annual accounts

BLUESTONE SRL

Director · represented by RANSART PAUL

Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE +11 more

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Gérardstraat 150

1040 Etterbeek

2.217.428.710

Koningin Astridlaan 272

1950 Kraainem

Active since 1 March 2013

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

Details

Company number
0521.688.764
VAT number
BE 0521.688.764
Registered office
Gérardstraat 150, 1040 Etterbeek
Names & denominations
PHARMARIVE
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
1 March 2013
Peppol
Active · Active since 24 Nov 2023
Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van holdings

Holdings

Frequently asked questions

What is the enterprise number of PHARMARIVE?
The enterprise number of PHARMARIVE is BE0521688764.
What is the address of PHARMARIVE?
The registered office of PHARMARIVE is located at Gérardstraat 150, 1040 Etterbeek.
When was PHARMARIVE founded?
PHARMARIVE was founded on 1 March 2013.
What is the main activity of PHARMARIVE?
The main activity of PHARMARIVE is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does PHARMARIVE have a website?
No website is currently known for PHARMARIVE.
How much profit did PHARMARIVE make in 2025?
PHARMARIVE recorded a loss after taxes of € 19,028 in financial year 2025.
What is the revenue of PHARMARIVE?
As a small company, PHARMARIVE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 166,358.
How many employees does PHARMARIVE have?
According to the 2025 annual accounts, PHARMARIVE has 1.9 full-time equivalents (FTE).
Where can I find the annual accounts of PHARMARIVE?
PHARMARIVE files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of PHARMARIVE?
According to the 2025 annual accounts, the directors of PHARMARIVE are: BLUESTONE SRL.
Who owns PHARMARIVE?
Behind PHARMARIVE is BLUESTONE SRL. BLUESTONE SRL is also behind COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS and IMMOLENANS.